Tower Research Capital LLC (Trc) Royalty Pharma PLC Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 19,795 shares of RPRX stock, worth $480,622. This represents 0.02% of its overall portfolio holdings.

Number of Shares

19,795

Previous 29,848 33.68%

Holding current value

$480,622

Previous $787,000 28.84%

% of portfolio

0.02%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$25.63 - $29.27 $257,658 - $294,251	-10,053 Reduced 33.68%	19,795 $560,000
Q2 2024 Aug 13, 2024	BUY	$26.26 - $29.9 $699,723 - $796,715	26,646 Added 832.17%	29,848 $787,000
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $402,371 - $459,078	-14,653 Reduced 82.07%	3,202 $97,000
Q4 2023 Feb 13, 2024	SELL	$26.21 - $29.22 $539,611 - $601,581	-20,588 Reduced 53.55%	17,855 $501,000
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $967,864 - $1.16 Million	36,857 Added 2323.9%	38,443 $1.04 Million
Q2 2023 Aug 14, 2023	SELL	$29.6 - $36.56 $11,455 - $14,148	-387 Reduced 19.61%	1,586 $48,000
Q1 2023 May 09, 2023	SELL	$32.77 - $39.4 $388,062 - $466,574	-11,842 Reduced 85.72%	1,973 $71,000
Q4 2022 Feb 10, 2023	BUY	$39.17 - $44.04 $432,240 - $485,981	11,035 Added 396.94%	13,815 $546,000
Q3 2022 Nov 10, 2022	SELL	$39.88 - $44.65 $138,184 - $154,712	-3,465 Reduced 55.48%	2,780 $112,000
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $13,360 - $15,742	356 Added 6.05%	6,245 $263,000
Q1 2022 May 12, 2022	SELL	$37.46 - $42.44 $378,683 - $429,025	-10,109 Reduced 63.19%	5,889 $229,000
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $507,784 - $613,326	14,438 Added 925.51%	15,998 $638,000
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $977,478 - $1.14 Million	-27,047 Reduced 94.55%	1,560 $57,000
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $961,819 - $1.13 Million	24,136 Added 539.83%	28,607 $1.17 Million
Q1 2021 May 17, 2021	BUY	$42.34 - $52.82 $102,208 - $127,507	2,414 Added 117.36%	4,471 $195,000
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $56,274 - $77,977	1,558 Added 312.22%	2,057 $103,000
Q3 2020 Nov 16, 2020	BUY	$38.56 - $48.36 $19,241 - $24,131	499 New	499 $21,000

Others Institutions Holding RPRX

# of Institutions

413

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Royalty Pharma PLC Transaction History